Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-02

Clinical Trial Update: Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational Study

View source ↗

Summary

Post-marketing observational study evaluating Lupron (leuprolide) in real-life management of prostate cancer; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lupron (leuprolide)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Prostate Cancer | Status: COMPLETED | Results posted: 2018-04-02